Literature DB >> 28425730

The relation of anxiety and cognition in Parkinson's disease.

Gretchen O Reynolds1, Kristine K Hanna1, Sandy Neargarder1, Alice Cronin-Golomb1.   

Abstract

OBJECTIVE: Parkinson's disease (PD) has long been conceptualized as a motor disorder, but nonmotor symptoms also manifest in the disease and significantly reduce quality of life. Anxiety and cognitive dysfunction are prevalent nonmotor symptoms, even in early disease stages, but the relation between these symptoms remains poorly understood. We examined self-reported anxiety and neurocognitive function, indexed by measures of executive function (set-shifting and phonemic fluency), categorical fluency, and attention/working memory. We hypothesized that anxiety would correlate with cognitive performance.
METHOD: The Beck Anxiety Inventory and cognitive tests (Trail Making, Verbal Fluency, Digit Span) were administered to 77 nondemented adults with mild to moderate idiopathic PD (39 men, 38 women; Mage = 62.9 years).
RESULTS: Higher anxiety was associated with more advanced disease stage and severity and with poorer set-shifting when using a derived metric to account for motoric slowing. Depression correlated with greater anxiety and disease severity, but not with cognitive performance.
CONCLUSIONS: Our findings support the association of anxiety with a specific domain of executive function, set-shifting, in nondemented individuals with mild to moderate PD, raising the possibility that treatment of anxiety may alleviate aspects of executive dysfunction in this population. (PsycINFO Database Record (c) 2017 APA, all rights reserved).

Entities:  

Mesh:

Year:  2017        PMID: 28425730      PMCID: PMC5578881          DOI: 10.1037/neu0000353

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  79 in total

Review 1.  Epidemiology of neurodegeneration.

Authors:  Richard Mayeux
Journal:  Annu Rev Neurosci       Date:  2003-01-24       Impact factor: 12.449

Review 2.  Affective symptoms and cognitive functions in Parkinson's disease.

Authors:  Michele Poletti; Anna De Rosa; Ubaldo Bonuccelli
Journal:  J Neurol Sci       Date:  2012-04-13       Impact factor: 3.181

3.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 5.  Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation.

Authors:  Angie A Kehagia; Graham K Murray; Trevor W Robbins
Journal:  Curr Opin Neurobiol       Date:  2010-02-16       Impact factor: 6.627

Review 6.  Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia.

Authors:  Kelly Del Tredici; Heiko Braak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-10-13       Impact factor: 10.154

7.  A longitudinal study of neuropsychological change in individuals with Parkinson's disease.

Authors:  Tamiko Azuma; Robyn F Cruz; Kathryn A Bayles; Cheryl K Tomoeda; E B Montgomery
Journal:  Int J Geriatr Psychiatry       Date:  2003-12       Impact factor: 3.485

8.  Parkinson's disease and anxiety: comorbidity with depression.

Authors:  M A Menza; D E Robertson-Hoffman; A S Bonapace
Journal:  Biol Psychiatry       Date:  1993-10-01       Impact factor: 13.382

9.  Emergence of nonmotor symptoms as the focus of research and treatment of Parkinson's disease: introduction to the special section on nonmotor dysfunctions in Parkinson's disease.

Authors:  Alice Cronin-Golomb
Journal:  Behav Neurosci       Date:  2013-04       Impact factor: 1.912

10.  Web-based assessment of visual and visuospatial symptoms in Parkinson's disease.

Authors:  Melissa M Amick; Ivy N Miller; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Parkinsons Dis       Date:  2012-03-20
View more
  9 in total

1.  Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort.

Authors:  Jacob D Jones; Natalie E Kurniadi; Taylor P Kuhn; Sarah M Szymkowicz; Joseph Bunch; Elizabeth Rahmani
Journal:  Neuropsychology       Date:  2019-07-25       Impact factor: 3.295

Review 2.  The Relationship Between Anxiety Disorders and Parkinson's Disease: Clinical and Therapeutic Issues.

Authors:  Sandra Abou Kassm; Wadih Naja; Ramzi Haddad; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2021-03-03       Impact factor: 5.285

Review 3.  Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.

Authors:  Stéphane Prange; Hélène Klinger; Chloé Laurencin; Teodor Danaila; Stéphane Thobois
Journal:  Drugs Aging       Date:  2022-06-16       Impact factor: 4.271

4.  Modifiable Comorbidities Associated with Cognitive Decline in Parkinson's Disease.

Authors:  Emily Forbes; Thomas F Tropea; Sneha Mantri; Sharon X Xie; James F Morley
Journal:  Mov Disord Clin Pract       Date:  2021-01-20

5.  Non-Motor Symptoms of Parkinson's Disease: The Neurobiology of Early Psychiatric and Cognitive Dysfunction.

Authors:  Ayan Hussein; Christopher A Guevara; Pamela Del Valle; Swati Gupta; Deanna L Benson; George W Huntley
Journal:  Neuroscientist       Date:  2021-05-08       Impact factor: 7.235

6.  Differentiating cognitive or motor dimensions associated with the perception of fall-related self-efficacy in Parkinson's disease.

Authors:  Taylor Chomiak; Alexander Watts; Jacqueline Burt; Richard Camicioli; Sun Nee Tan; Martin J McKeown; Bin Hu
Journal:  NPJ Parkinsons Dis       Date:  2018-08-20

7.  Anxiety, Depression, and Apathy as Predictors of Cognitive Decline in Patients With Parkinson's Disease-A Three-Year Follow-Up Study.

Authors:  Ketevan Toloraia; Antonia Meyer; Selina Beltrani; Peter Fuhr; Roselind Lieb; Ute Gschwandtner
Journal:  Front Neurol       Date:  2022-02-08       Impact factor: 4.003

8.  Human state anxiety classification framework using EEG signals in response to exposure therapy.

Authors:  Farah Muhammad; Saad Al-Ahmadi
Journal:  PLoS One       Date:  2022-03-18       Impact factor: 3.240

9.  Anxiety disorders are associated with verbal memory impairment in patients with Parkinson's disease without dementia.

Authors:  Nadeeka N Dissanayaka; Elana J Forbes; Ji Hyun J Yang; Dana Pourzinal; John D O'Sullivan; Leander K Mitchell; David A Copland; Katie L McMahon; Gerard J Byrne
Journal:  J Neurol       Date:  2021-08-04       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.